GSDME and lung carcinoma: Moreover, Zhang et al. reported that both paclitaxel, as well as cisplatin, could trigger the caspase‐3/GSDME signaling pathway and convert the cell death pathway from apoptosis to pyroptosis, in order to suppress the proliferation of lung cancer cells.72